News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,723 Results
Type
Article (14348)
Company Profile (105)
Press Release (260262)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88553)
Career Advice (466)
Deals (15492)
Drug Delivery (73)
Drug Development (36808)
Employer Resources (50)
FDA (6402)
Job Trends (6247)
News (151207)
Policy (14179)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (445)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23372)
ALS (56)
Alzheimer's disease (478)
Antibody-drug conjugate (ADC) (101)
Approvals (6595)
Artificial intelligence (201)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4374)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1320)
Cardiovascular disease (151)
Career advice (419)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32103)
Collaboration (725)
Compensation (325)
Complete response letters (33)
COVID-19 (778)
CRISPR (43)
C-suite (434)
Cystic fibrosis (58)
Data (1825)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1385)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33598)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39076)
Executive appointments (532)
FDA (7506)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (432)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (440)
Government (1405)
Grass and pollen (4)
Guidances (165)
Healthcare (3612)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (842)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5948)
IRA (33)
Job creations (2067)
Job search strategy (375)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (206)
Leadership (8)
Legal (3466)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1310)
Medtech (1318)
Mergers & acquisitions (9964)
Metabolic disorders (435)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (37)
Neuroscience (888)
Neurotech (1)
NextGen: Class of 2026 (1593)
Non-profit (602)
Now hiring (17)
Obesity (228)
Opinion (142)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (81)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29825)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8331)
Phase 2 (13538)
Phase 3 (12234)
Pipeline (1909)
Policy (135)
Postmarket research (1422)
Preclinical (3347)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (136)
Rare diseases (350)
Real estate (2664)
Recruiting (18)
Regulatory (10992)
Reports (15)
Research institute (576)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (81)
Series B (49)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1651)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (232)
Venture capital (32)
Weight loss (141)
Women's health (27)
Worklife (4)
Date
Today (2)
Last 7 days (179)
Last 30 days (737)
Last 365 days (10454)
2026 (954)
2025 (10730)
2024 (12519)
2023 (14257)
2022 (19590)
2021 (20122)
2020 (19108)
2019 (14947)
2018 (11756)
2017 (13916)
2016 (13152)
2015 (15494)
2014 (12438)
2013 (10670)
2012 (11458)
2011 (11970)
2010 (10939)
Location
Africa (319)
Alabama (19)
Alaska (1)
Arizona (78)
Arkansas (3)
Asia (20988)
Australia (2693)
California (3185)
Canada (1481)
China (551)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (41174)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (246)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (421)
Massachusetts (2591)
Michigan (46)
Minnesota (166)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1396)
New Mexico (7)
New York (906)
North Carolina (619)
North Dakota (2)
Northern California (1449)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (717)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1393)
Tennessee (53)
Texas (455)
United States (12692)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (223)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,723 Results for "elan pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway into the Clinic
February 3, 2026
·
4 min read
Press Releases
Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor
November 10, 2025
·
6 min read
Press Releases
Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway
April 25, 2025
·
4 min read
Press Releases
Onchilles Expands Leadership Team to Advance First-in-Class Pan-Cancer Therapeutics Targeting the ELANE Pathway into Clinical Trials
January 13, 2025
·
4 min read
Press Releases
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at SITC 2024
November 7, 2024
·
4 min read
Elanco to Participate in Stifel 2024 Jaws and Paws Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024.
May 21, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
November 11, 2025
·
5 min read
Elanco to Participate in Upcoming Investor Conferences
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.
February 22, 2024
·
1 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
Business
Elanco Appoints Shiv O’Neill as General Counsel and Corporate Secretary
Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O’Neill as the company’s Executive Vice President, General Counsel and Corporate Secretary.
March 4, 2024
·
2 min read
1 of 27,473
Next
